Answer
Emmanuelle Charpentier is the Director at the Max Planck Unit for the Science of Pathogens in Berlin, Germany. Her research focuses on understanding the molecular mechanisms underlying bacterial infections and developing new strategies to combat them. She has made significant contributions to the development of CRISPR-Cas9 genome editing technology, which has revolutionized the field of genetics.